Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Moodys
Cipla
Mallinckrodt
Fish and Richardson

Generated: May 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,067,555

« Back to Dashboard

Which drugs does patent 7,067,555 protect, and when does it expire?

Patent 7,067,555 protects ZOLOFT and is included in one NDA.

Protection for ZOLOFT has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-two patent family members in forty-five countries.

Summary for Patent: 7,067,555
Title:Sertraline oral concentrate
Abstract:The present invention provides an essentially nonaqueous, liquid pharmaceutical concentrate composition for oral administration containing sertraline or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients. The present invention also provides a use of this concentrate composition to prepare an aqueous solution of sertraline. In addition, the present invention provides a method of using this concentrate composition to treat or prevent a variety of diseases or conditions. Finally, the present invention provides the compound, (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalena- mine methanesulfonate.
Inventor(s): Harper; Nancy J. (Groton, CT), Ranade; Gautam R. (East Lyme, CT), Welch; Willard M. (Mystic, CT)
Assignee: Pfizer Inc (New York, NY)
Application Number:10/771,985
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 7,067,555
Patent Claim Types:
see list of patent claims
Composition; Formulation; Dosage form; Compound; Use;

Drugs Protected by US Patent 7,067,555

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Pfizer ZOLOFT sertraline hydrochloride CONCENTRATE;ORAL 020990-001 Dec 7, 1999 AA RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Medtronic
Harvard Business School
Queensland Health
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.